aDepartment of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, United Kingdom
bNational Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, United Kingdom
cDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
dMRC Laboratory of Medical Sciences, London, United Kingdom
eInstitute of Clinical Sciences, Imperial College London, London, United Kingdom
fDepartment of Inflammation and Ageing, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, United Kingdom
gUniversity Hospital of Würzburg, Germany
hDepartment of Medicine, University Hospital Hamburg, Germany
iAmedes MVZ Hamburg, Hamburg, Germany
jNewcastle University, Newcastle upon Tyne NHS Foundation Trust, United Kingdom
kUniversity of Sheffield, Sheffield, United Kingdom
lCardiff University, Cardiff, United Kingdom
mMedizinische Klinik und Poliklinik IV, LMU Klinikum München, Germany
nMedicover Neuroendocrinology Munich, Munich, Germany
oNeurocrine UK Ltd, Cardiff, United Kingdom
∗Corresponding author. r.j.ross@sheffield.ac.uk